Loading viewer...
other
Format: PDF other
Shareholder letter from Elliott Associates and Elliott International, representing over 12% ownership in Arconic, addressing the Board of Directors regarding CEO performance and strategic direction. The letter critiques current leadership's operational performance, challenges the Board's defense of management, and advocates for leadership changes to improve shareholder returns.
Catalyst Pharmaceuticals 2021 SASB Sustainability Index
otherother
15 Pages
Catalyst Pharmaceuticals
report
29 Pages
ΤΙΤΑΝ
Bespoke Investment 2017: 100 Days Trump Stock Market Analysis
otherother
40 Pages
Bespoke Investment Group
Mutual Funds Chapter 7 ICAI 2021 Guide
otherother
34 Pages
The Institute of Chartered Accountants of India
Bespoke Investment Group 2017 Housing Report
otherother
7 Pages
Bespoke Investment Group